Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Mohan, M., Shah, N., Luan, D., Monge, J., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al Hadidi, S., Cooper, D. L., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2023). Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study. Blood, 142(Supplement 1), 545–545. https://doi.org/10.1182/blood-2023-174875
Authors:
Meera Mohan
Nishi Shah
Danny Luan
Jorge Monge
Mark Forsberg
Vineel Bhatlapenumarthi
Metodi Balev
Anannya Patwari
Heloise Cheruvalath
Divaya Bhutani
Sharmilan Thanendrarajan
Binod Dhakal
Maurizio Zangari
Samer Al Hadidi
Dennis Cooper
Suzanne Lentzsch
Frits van Rhee
Anita D’Souza
Anikó Szabó
Carolina Schinke
Rajshekhar Chakraborty
Affiliated Authors:
Danny Luan
Metodi Balev
Divaya Bhutani
Suzanne Lentzsch
Rajshekhar Chakraborty
Columbia Affiliation:
Subjects:
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Targeted Protein Degradation in Biomedical Research (OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
elink
Publication Type:
Conference Proceeding
Unique ID:
10.1182/blood-2023-174875
DOI:
10.1182/blood-2023-174875
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: